Grant Details

General Overview

Grant Information

Grant name: Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

Funding organization: National Institutes of Health (NIH)

Total funding amount: Not specified

Duration: Maximum project period of 5 years

Primary objective: Advance mechanistic and translational research on mood and psychotic disorders during the menopausal transition.

Key stakeholders: Women experiencing menopausal transition, researchers in mental health.

Funding source: NIH

Funding type: Grant

Significance: Addresses an unmet need in mental health research related to menopause.

Grant frequency: Recurring with multiple application deadlines.

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

For-Profit Organizations

Small Businesses

Local Governments

State Governments

County Governments

City or Township Governments

Indian/Native American Tribal Governments (Federally Recognized)

Indian/Native American Tribal Governments (Other than Federally Recognized)

Foreign Organizations

Specific Qualifications

Organizations must complete registrations with SAM, eRA Commons, and Grants.gov.

Principal Investigators must have an eRA Commons account.

Scope and Focus

Research Focus Areas

Mechanistic and translational research on mood and psychotic disorders during the menopausal transition.

Understanding neurobiological and behavioral mechanisms.

Identification of novel targets for mental health interventions.

Target Beneficiaries

Women transitioning through menopause.

Technical Details

Technical Expertise Requirements

Teams should include members from neuroscience, engineering, endocrinology, epidemiology, reproductive medicine, gerontology, gynecology, pharmacology, psychiatry, and psychology.

Financial Structure

Budget Information

Application budgets are not limited but must reflect the actual needs of the proposed project.

Timeline and Implementation

Key Dates

Open Date: January 5, 2025

Application Due Dates: Multiple deadlines until January 8, 2028.

Compliance and Requirements

Regulatory Compliance

Must comply with NIH Grants Policy Statement and federal regulations.

Application Process

Submission Instructions

Applications must be submitted electronically via Grants.gov.

Follow the instructions in the How to Apply - Application Guide.

Grant Details

mental health psychosis menopause research clinical trials neuroscience behavioral science women's health
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
PAR-25-281
NIH Grants
EDU NGO ENTERPRISE PUBLIC RESEARCH SME OTHER
US
HEALTHCARE OTHER
DEVELOPMENT OTHER
OTHER
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
None
None
None
USD
None
Jan. 8, 2028, 10 p.m.
Not specified